Thomas Woiwode, Director at CRISPR Therapeutics AG (CRSP), sold 121,362 shares at $50.31 ($6.1M) on 2018-05-07, disclosed to the SEC on 2018-05-09.
Open-market sale of $6.1M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.31 | 3,172 | $160K | 2.6% |
| 2 | $50.31 | 7,424 | $374K | 6.1% |
| 3 | $50.31 | 2,862 | $144K | 2.4% |
| 4 | $50.31 | 97,550 | $4.9M | 80.2% |
| 5 | $51.26 | 225 | $12K | 0.2% |
| 6 | $51.26 | 249 |
| $13K |
| 0.2% |
| 7 | $51.26 | 582 | $30K | 0.5% |
| 8 | $51.26 | 7,645 | $392K | 6.4% |
| 9 | $51.45 | 1,653 | $85K | 1.4% |
| Total | $50.39 avg | 121,362 | $6.1M | 100% |
| Filing → |
| ALGS | BUY | 2020-10-20 | $3.0M | — | Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |
| CRSP | SELL | 2018-05-17 | $2.6M | — | Filing → |